HIMS — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Hims & Hers Health, Inc.
Healthcare · $19.14
1.0
/10
Avoid
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-51.9%
Below trend
Volatility
Normal
Average premiums
Momentum
Decelerating
Price direction
About Hims & Hers Health, Inc.
Telehealth and DTC wellness platform offering GLP-1 access, skincare, and hair loss treatments. No dividend, high beta, sentiment-driven. Regulatory headlines create constant catalysts. Rich premiums but news risk cuts both ways — not for autopilot sellers.
Drug Manufacturers - Specialty & Generic
Market Cap
$4.4B
P/E Ratio
37.5
Beta
2.31
52-Week Range Current: $19.14
$13.74 $70.43
Earnings
2026-05-04
29 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE